Search results for "United States"

showing 10 items of 383 documents

Fish Intake in Pregnancy and Child Growth: A Pooled Analysis of 15 European and US Birth Cohorts

2016

Importance Maternal fish intake in pregnancy has been shown to influence fetal growth. The extent to which fish intake affects childhood growth and obesity remains unclear. Objective To examine whether fish intake in pregnancy is associated with offspring growth and the risk of childhood overweight and obesity. Design, Setting, and Participants Multicenter, population-based birth cohort study of singleton deliveries from 1996 to 2011 in Belgium, France, Greece, Ireland, Italy, the Netherlands, Norway, Poland, Portugal, Spain, and Massachusetts. A total of 26 184 pregnant women and their children were followed up at 2-year intervals until the age of 6 years. Exposures Consumption of fish dur…

MalePediatric ObesityPediatricsChild growthFetal Development/physiologyOverweightBody Mass IndexCohort StudiesFetal DevelopmentChild Development0302 clinical medicinePregnancyRisk Factors030212 general & internal medicineChild2. Zero hungereducation.field_of_studyFish intakeFishes3. Good healthEuropePediatric Obesity/epidemiologyChild PreschoolFemalemedicine.symptomCohort studymedicine.medical_specialtyOffspringPopulation030209 endocrinology & metabolismOverweight/epidemiologyArticleChildhood obesity03 medical and health sciencesmedicineAnimalsHumanseducationNutritionPregnancyPrenatal nutritionbusiness.industryInfant NewbornInfantOverweightmedicine.diseaseUnited StatesDietPregnancy ComplicationsSeafoodPediatrics Perinatology and Child HealthHuman medicinebusinessBody mass indexFollow-Up StudiesDemography
researchProduct

Estimated prevalence of undiagnosed atrial fibrillation in the United States.

2017

Introduction As atrial fibrillation (AF) is often asymptomatic, it may remain undiagnosed until or even after development of complications, such as stroke. Consequently the observed prevalence of AF may underestimate total disease burden. Methods To estimate the prevalence of undiagnosed AF in the United States, we performed a retrospective cohort modeling study in working age (18-64) and elderly (≥65) people using commercial and Medicare administrative claims databases. We identified patients in years 2004-2010 with incident AF following an ischemic stroke. Using a back-calculation methodology, we estimated the prevalence of undiagnosed AF as the ratio of the number of post-stroke AF patie…

MalePediatricsSocial Scienceslcsh:MedicineBlood Pressure030204 cardiovascular system & hematologyVascular Medicine0302 clinical medicineElderlyEndocrinologyRisk FactorsEpidemiologyAtrial FibrillationPrevalenceMedicine and Health Sciences030212 general & internal medicineYoung adultlcsh:ScienceStrokeAged 80 and overeducation.field_of_studyMultidisciplinaryData CollectionAtrial fibrillationMiddle AgedStrokeHemorrhagic StrokeNeurologyHypertensionFemalemedicine.symptomArrhythmiaResearch ArticleAdultmedicine.medical_specialtyAdolescentEndocrine DisordersCerebrovascular DiseasesPolitical SciencePopulationCardiologyPublic PolicyMedicareAsymptomaticRisk Assessment03 medical and health sciencesYoung AdultmedicineDiabetes MellitusHumanseducationDisease burdenAgedProbabilityRetrospective StudiesIschemic Strokebusiness.industrylcsh:RAnticoagulantsRetrospective cohort studymedicine.diseaseUnited StatesAge GroupsGeriatricsMetabolic DisordersPeople and PlacesPopulation Groupingslcsh:QbusinessPLoS ONE
researchProduct

Association between ideal cardiovascular health and risk of sudden cardiac death and all-cause mortality among middle-aged men in Finland.

2020

Abstract Background Strong associations have been demonstrated between the American Heart Association’s cardiovascular health (CVH) metrics and various cardiovascular outcomes, but the association with sudden cardiac death (SCD) is uncertain. We examined the associations between these CVH metrics and the risks of SCD and all-cause mortality among men in Finland. Methods and results We used the prospective population-based Kuopio Ischaemic Heart Disease cohort study, which consists of men between 42 and 60 years of age at baseline. CVH metrics were computed for 2577 men with CVH scores at baseline ranging from 0 to 7, categorized into CVH scores of 0–2 (poor), 3–4 (intermediate) and 5–7 (ide…

MalePediatricsmedicine.medical_specialtyEpidemiologyCardiovascular healthHealth Status030204 cardiovascular system & hematologySudden cardiac deathCohort Studies03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumans030212 general & internal medicineMiddle-aged adultProspective StudiesAssociation (psychology)FinlandIdeal (set theory)business.industryMiddle Agedmedicine.diseaseUnited StatesDeath Sudden CardiacCardiovascular DiseasesCardiology and Cardiovascular MedicinebusinessCardiovascular outcomesAll cause mortalityEuropean journal of preventive cardiology
researchProduct

Validation of STA-Liatest D-Di assay for exclusion of pulmonary embolism according to the latest Clinical and Laboratory Standard Institute/Food and …

2017

: Combined clinical pretest probability (PTP) and D-dimer testing have great diagnostic value for pulmonary embolism exclusion. To harmonize performance levels of D-dimer assays available on the market, the Clinical and Laboratory Standard Institute (CLSI) has published a guideline, endorsed by the US Food and Drug Administration (FDA). Such guideline specifies the ideal D-dimer assay characteristic and target population. This study was conducted following the CLSI guideline to upgrade the assay-intended use and obtain FDA clearance of STA-Liatest D-Di assay for pulmonary embolism exclusion in patient with low/moderate PTP. This was an international, multicenter, prospective nonrandomized, …

MalePediatricsmedicine.medical_specialtypulmonary embolism030204 cardiovascular system & hematologyFood and drug administrationFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineProspective StudiesSTA-Liatest D-Dibusiness.industryUnited States Food and Drug AdministrationClinical and Laboratory Standard InstituteFood and Drug AdministrationHematologyGeneral MedicineGuidelineOriginal ArticlesMiddle Agedmedicine.diseaseThrombosisConfidence intervalUnited StatesPulmonary embolismPre- and post-test probabilityD-dimerEmergency medicineAmbulatoryBiological AssayFemalebusinessVenous thromboembolismBlood coagulationfibrinolysis : an international journal in haemostasis and thrombosis
researchProduct

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (E…

2015

Summary Background Alisporivir (ALV) is an oral, host-targeting agent with pangenotypic anti-hepatitis C virus (HCV) activity and a high barrier to resistance. Aim To evaluate efficacy and safety of ALV plus peginterferon-α2a and ribavirin (PR) in treatment-naive patients with chronic HCV genotype 1 infection. Methods Double-blind, randomised, placebo-controlled, Phase 3 study evaluating ALV 600 mg once daily [response-guided therapy (RGT) for 24 or 48 weeks or 48 weeks fixed duration] or ALV 400 mg twice daily RGT with PR, compared to PR alone. Following a Food and Drug Administration partial clinical hold, ALV/placebo was discontinued and patients completed treatment with PR only. At that…

MalePhases of clinical researchHepacivirusGastroenterologyPolyethylene GlycolPolyethylene Glycolschemistry.chemical_compoundMedicinePharmacology (medical)ChronicAlisporivirAdolescent; Adult; Aged; Antiviral Agents; Cyclosporine; Double-Blind Method; Drug Therapy Combination; Female; Genotype; Hepacivirus; Hepatitis C Chronic; Humans; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome; United States; Young AdultGastroenterologyHepatitis CRecombinant ProteinMiddle AgedHepatitis CRecombinant ProteinsTreatment OutcomeCombinationCyclosporineDrug Therapy CombinationFemaleHumanUnited StateAdultmedicine.medical_specialtyAdolescentGenotypeAlpha interferonPlaceboAntiviral AgentsYoung AdultDrug TherapyDouble-Blind MethodInternal medicineRibavirinHumansAdverse effectAgedAntiviral AgentHepaciviruHepatologybusiness.industryRibavirinInterferon-alphaHepatitis C Chronicmedicine.diseaseUnited StatesRegimenchemistryImmunologybusinessAlimentary pharmacologytherapeutics
researchProduct

Personal, social, and environmental factors associated with lifejacket wear in adults and children: A systematic literature review.

2018

© 2018 Peden et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Objective Drowning claims 7% of the global burden of injury-related deaths. Lifejackets are routinely recommended as a drowning prevention strategy; however, a review of related factors regarding lifejacket wear has not previously been investigated. Methods This systematic review examined literature published from inception to December 2016 in English and German languages. The personal, social, and environmental factors associated with lif…

MalePhysiologyEthnic groupPsychological interventionpelastusliivitlcsh:MedicineTransportationAdolescentsGeographical locationsFamilies0302 clinical medicineMedicine and Health Sciencesadults030212 general & internal medicineturvallisuuskulttuuriYoung adultlcsh:ScienceChildChildrenaikuisetAlcohol ConsumptionMultidisciplinaryQualitative StudiesResearch AssessmentSystematic reviewlife jacketsResearch DesignEngineering and TechnologyFemale0305 other medical sciencePsychologyResearch ArticleWashingtonAdultSystematic ReviewsAdolescentympäristötekijätchildren (age groups)General Science & TechnologyMEDLINElapset (ikäryhmät)socioeconomic factorsResearch and Analysis Methodssafety culture03 medical and health sciencesYoung Adultenvironmental factorsEnvironmental healthHumanssosioekonomiset tekijätSwimmingShipsNutrition030505 public healthDrowningBiological LocomotionPreventionlcsh:RBiology and Life SciencesEvidence-based medicineBoatsUnited StatesDietAge GroupsPeople and PlacesNorth AmericaHousehold incomePopulation Groupingslcsh:QEmergencieshuman activitiesQualitative research
researchProduct

Comparison of rehospitalization rates in France and the United States

2014

Objective To compare rates of 30-day all-cause rehospitalization in France and the US among patients aged 65 years and older and explain any difference between the countries. Methods To calculate rehospitalization rates in France, we use an individual identifying variable in the national hospital administrative dataset to track unique individuals aged 65 years or more hospitalized in France in 2010. To calculate the proportion of rehospitalized patients (65+) who received outpatient visits between the time of initial discharge and rehospitalization, we linked the hospital database with a database that includes all medical and surgical admissions. We used step by step regression models to pr…

MalePopulationComorbidityPrimary carePatient ReadmissionSeverity of Illness IndexInsurance Claim ReviewSex FactorsAmbulatory CaremedicineHumanseducationHealth policyAgedAged 80 and overeducation.field_of_studybusiness.industryHealth PolicyAge FactorsPublic Health Environmental and Occupational HealthMedicare beneficiarymedicine.diseaseUnited StatesOutpatient visitsFemaleFranceHealth Services ResearchMedical emergencyNursing homesbusinessDemographyJournal of Health Services Research & Policy
researchProduct

Bladder cancer index: cross-cultural adaptation into Spanish and psychometric evaluation.

2014

Background: The Bladder Cancer Index (BCI) is so far the only instrument applicable across all bladder cancer patients, independent of tumor infiltration or treatment applied. We developed a Spanish version of the BCI, and assessed its acceptability and metric properties. Methods: For the adaptation into Spanish we used the forward and back-translation method, expert panels, and cognitive debriefing patient interviews. For the assessment of metric properties we used data from 197 bladder cancer patients from a multi-center prospective study. The Spanish BCI and the SF-36 Health Survey were self-administered before and 12 months after treatment. Reliability was estimated by Cronbach’s alpha.…

MalePsychometricsAparell urinariSurveys and QuestionnairesProspective cohort studyCàncermedia_commonLanguageCognitionGeneral MedicinePatient outcomeControl de qualitatNeoplasias de la Vejiga UrinariaEstudios de ValidaciónPsicometríaBufeta -- CàncerFemalePsicometriaClinical psychologyCross-Cultural ComparisonQuality of lifemedicine.medical_specialtyPsychometricsUrinary bladder neoplasms:Psychiatry and Psychology::Behavioral Disciplines and Activities::Psychological Tests::Psychometrics [Medical Subject Headings]:Publication Characteristics::Study Characteristics::Validation Studies [Medical Subject Headings]Cronbach's alpha:Disciplines and Occupations::Social Sciences::Quality of Life [Medical Subject Headings]medicine:Diseases::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Urologic Neoplasms::Urinary Bladder Neoplasms [Medical Subject Headings]media_common.cataloged_instanceHumansEuropean UnionEuropean unionAgedNeoplasm StagingGynecologyAnalysis of VarianceBladder cancerbusiness.industryResearchPublic Health Environmental and Occupational HealthConstruct validityTranslatingmedicine.diseaseCross-cultural studiesUnited StatesValidation studiesPatient outcomesCalidad de VidabusinessHealth and quality of life outcomes
researchProduct

Identification of optimal device combinations for the chimney endovascular aneurysm repair technique within the PERICLES registry

2018

Abstract Objective The ideal stent combination for chimney endovascular aneurysm repair remains undetermined. Therefore, we sought to identify optimal aortic and chimney stent combinations that are associated with the best outcomes by analyzing the worldwide collected experience in the PERformance of chImney technique for the treatment of Complex aortic pathoLogiES (PERICLES) registry. Methods The PERICLES registry was reviewed for patients with pararenal aortic disease electively treated from 2008 to 2014. Eleven different aortic devices were identified with three distinct subgroups: group A (n = 224), nitinol/polyester; group B (n = 105), stainless steel/polyester; and group C (n = 69), n…

MaleRegistrieTime FactorsEndoleakmedicine.medical_treatmentComorbidity030204 cardiovascular system & hematology030230 surgeryEndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareAortic aneurysm0302 clinical medicineRisk FactorsRetrospective StudieOcclusionOdds RatioStentRegistriesMultivariate AnalysiPolytetrafluoroethyleneAged 80 and overEndovascular ProceduresHazard ratioGraft Occlusion VascularEuropeBlood Vessel ProsthesiTreatment OutcomeCardiothoracic surgeryStentsFemaleCardiology and Cardiovascular MedicineSTENT GRAFT; CHIMENY GRAFT; CHIMNEY TECHINQUEHumanUnited Statemedicine.medical_specialtyHospitals Low-VolumeTime FactorPolyestersPolyesterProsthesis DesignDisease-Free Survival03 medical and health sciencesBlood Vessel Prosthesis ImplantationBlood vessel prosthesisAlloysmedicineHumansProportional Hazards ModelsRetrospective StudiesAgedEndovascular ProcedureAortic Aneurysm Thoracicbusiness.industryRisk FactorStentOdds ratiomedicine.diseaseStainless SteelUnited StatesBlood Vessel ProsthesisSurgeryMultivariate AnalysisAlloyProportional Hazards ModelSurgerybusinessHospitals High-VolumeAortic Aneurysm Abdominal
researchProduct

Outcomes of Patients With Asymptomatic Aortic Stenosis Followed Up in Heart Valve Clinics

2018

International audience; Importance - The natural history and the management of patients with asymptomatic aortic stenosis (AS) have not been fully examined in the current era. Objective - To determine the clinical outcomes of patients with asymptomatic AS using data from the Heart Valve Clinic International Database. Design, setting, and participants - This registry was assembled by merging data from prospectively gathered institutional databases from 10 heart valve clinics in Europe, Canada, and the United States. Asymptomatic patients with an aortic valve area of 1.5 cm2 or less and preserved left ventricular ejection fraction (LVEF) greater than 50% at entry were considered for the prese…

MaleRegistrieUnited StateCanadamedicine.medical_specialty030204 cardiovascular system & hematologyAsymptomaticSudden deathDisease-Free Survival03 medical and health sciences0302 clinical medicineAortic valve replacementRetrospective StudieInternal medicinemedicineHumansProspective StudiesRegistries030212 general & internal medicineHeart valveWatchful WaitingProspective cohort studyRetrospective StudiesAgedAged 80 and overAsymptomatic DiseaseEjection fractionbusiness.industryDisease ManagementAortic Valve StenosisMiddle Agedmedicine.diseaseAortic Valve StenosiUnited States3. Good healthEuropeProspective StudieStenosisDeath Sudden Cardiacmedicine.anatomical_structureAortic valve stenosisAsymptomatic DiseasesCardiology[SDV.IB]Life Sciences [q-bio]/BioengineeringFemalemedicine.symptombusinessCardiology and Cardiovascular MedicineHuman
researchProduct